# Non-Interventional Study (NIS) Collecting Experiences For IPF in Taiwan

> **NCT03242759** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 101 (actual)

## Conditions studied

- Pulmonary Fibrosis

## Interventions

- **DRUG:** nintedanib
- **DRUG:** pirfenidone

## Key facts

- **NCT ID:** NCT03242759
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-17
- **Primary completion:** 2020-02-18
- **Final completion:** 2020-02-18
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2021-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03242759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03242759, "Non-Interventional Study (NIS) Collecting Experiences For IPF in Taiwan". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03242759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*